BENJAMÍN
FERNÁNDEZ GUTIÉRREZ
Profesor asociado de Ciencias de la Salud
![Foto de BENJAMÍN](/img/nophoto.png)
![Foto de Universidad Autónoma de Madrid](/img/noimage_org.png)
Universidad Autónoma de Madrid
Madrid, EspañaUniversidad Autónoma de Madrid-ko ikertzaileekin lankidetzan egindako argitalpenak (24)
2020
-
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease
Scientific Reports, Vol. 10, Núm. 1
2019
-
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways
Nature Communications, Vol. 10, Núm. 1
2016
-
LILRA3 deficiency is not involved in the giant cell arteritis and systemic sclerosis predisposition
Clinical and Experimental Rheumatology
2015
-
A genetic study on C5-TRAF1 and progression of joint damage in rheumatoid arthritis
Arthritis Research and Therapy, Vol. 17, Núm. 1
-
Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis
Clinical and Experimental Rheumatology, Vol. 33, pp. 31-35
-
Efficacy of supraspinatus tendon repair using mesenchymal stem cells along with a collagen I scaffold
Journal of Orthopaedic Surgery and Research, Vol. 10, Núm. 1
2014
-
A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility
Arthritis Research and Therapy, Vol. 16, Núm. 1
2013
-
Leflunomide discontinuation in rheumatoid arthritis and influence of associated disease-modifying anti-rheumatic drugs: A survival analysis
Scandinavian Journal of Rheumatology, Vol. 42, Núm. 6, pp. 433-436
-
SMAD3 rs17228212 Gene Polymorphism Is Associated with Reduced Risk to Cerebrovascular Accidents and Subclinical Atherosclerosis in Anti-CCP Negative Spanish Rheumatoid Arthritis Patients
PLoS ONE, Vol. 8, Núm. 10
2012
-
Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis
Arthritis Research and Therapy, Vol. 14, Núm. 3
-
Association of the methionine sulfoxide reductase A rs10903323 gene polymorphism with cardiovascular disease in patients with rheumatoid arthritis
Scandinavian Journal of Rheumatology, Vol. 41, Núm. 5, pp. 350-353
-
Evaluation of a shared autoimmune disease-associated polymorphism of TRAF6 in systemic sclerosis and giant cell arteritis
Journal of Rheumatology, Vol. 39, Núm. 6, pp. 1275-1279
-
Influence of the IL6 gene in susceptibility to systemic sclerosis
Journal of Rheumatology, Vol. 39, Núm. 12, pp. 2294-2302
2010
-
Association between IL-18 gene polymorphisms and biopsy-proven giant cell arteritis
Arthritis Research and Therapy, Vol. 12, Núm. 2
-
Lack of association between IFNGR1 gene polymorphisms and biopsy-proven giant cell arteritis
Clinical and Experimental Rheumatology, Vol. 28, Núm. 1 SUPPL. 57
-
Lack of association between IRF5 gene polymorphisms and biopsy-proven giant cell arteritis
Journal of Rheumatology, Vol. 37, Núm. 1, pp. 136-140
-
Lack of association between TRAF1/C5 gene polymorphisms and biopsy-proven giant cell arteritis
Journal of Rheumatology, Vol. 37, Núm. 1, pp. 131-135
-
Lack of association between hypoxia inducible factor-1 alpha gene polymorphisms and biopsy-proven giant cell arteritis
Clinical and Experimental Rheumatology, Vol. 28, Núm. 1 SUPPL. 57
-
Lack of association between the rs6920220 (G/A) polymorphism of the 6q23 region and biopsy-proven giant cell arteritis
Journal of Rheumatology, Vol. 37, Núm. 5, pp. 1020-1023
-
Role of BANK1 gene polymorphisms in biopsy-proven giant cell arteritis
Journal of Rheumatology, Vol. 37, Núm. 7, pp. 1502-1504